Amanda is a recognized, focused and innovative leader in the capital markets and life sciences space.
She advises life sciences and technology companies with respect to corporate finance, SEC reporting and governance matters. Amanda has represented issuers and underwriters in a wide variety of public and private financing transactions, including initial public offerings, follow-on and secondary offerings, SPACs, at-the-market offerings, private investment in public equity (PIPEs), and preferred stock and debt financings.
Amanda also advises late-stage private companies with respect to general corporate governance and liquidity preparation and public companies on corporate and securities law compliance and disclosure matters, including corporate governance best practices, Exchange Act reporting obligations and stock exchange requirements.
Chambers USA ranks Amanda as a top capital markets lawyer. In 2022, Amanda was highlighted by The Legal 500 as among the leading lawyers in U.S. capital markets and healthcare: life sciences.
Amanda is an exceptional attorney and adviser who can tackle the most complex of matters."
Chambers USA, Client Quote
2023 Edition
Recognition Recognition Recognition
Recognition Recognition Recognition
2023-2024
Chambers USA ranked Amanda as a leading lawyer in Capital Markets: Debt & Finance in California and the Western United States.
2019-2021
Recognized Amanda as a leading lawyer in Capital Markets: Debt & Equity in the Western United States
2020 & 2022-2023
Listed Amanda among the leading lawyers in U.S. Capital Markets: Equity Offerings
2019
Included Amanda on its shortlist for U.S. Rising Star – Financial & Corporate